Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
05/2012
05/30/2012CN102038915B Traditional Chinese medicament for treating hysteromyoma and preparation method thereof
05/30/2012CN102028832B Chinese medical compound emulsion for treating demodicidosis of human bodies and preparation method thereof
05/30/2012CN102000232B Chinese traditional medicine plaster for treating ecthyma and preparation method thereof
05/30/2012CN102000153B Hair growth lotion for promoting hair to grow
05/30/2012CN102000023B Momestasone furoate cream and preparation method thereof
05/30/2012CN101991707B Traditional Chinese medicine ointment for treating scalds and preparation method thereof
05/30/2012CN101987194B Chinese herbal medicine for treating chilblain
05/30/2012CN101978975B Haematococcus extract preparation, and preparation method and use thereof
05/30/2012CN101972463B Chinese medicinal composition for treating chilblain and preparation method thereof
05/30/2012CN101961350B Preparation method of fishy smell-removed pearl powder
05/30/2012CN101904915B Chinese medicinal composition for promoting fast recovery of burn
05/30/2012CN101904831B Application of alkannin and compositions thereof
05/30/2012CN101822696B Medicine composite for treating burn and scald and preparation method thereof
05/30/2012CN101797256B Application of oleanolic acid in preparation of medicaments for treating skin scar
05/30/2012CN101766731B Tea polyphenol acne resistant external preparation
05/30/2012CN101717693B Artemisia frigida willd essential oil and preparation method and application thereof
05/30/2012CN101480484B Method for preparing miraculous powder preparation of ledebouriella
05/30/2012CN101402675B Target restraint alpha Nu beta3 positive cell proliferation cyclic peptides
05/30/2012CN101401879B Pill for treating acne on face
05/30/2012CN101385794B Guizhen medicine for treating burn
05/30/2012CN101336979B Liquid medicine for ordinary wound
05/30/2012CN101332251B Decoction for treating wind-heat type drug dermatitis
05/30/2012CN101317889B Decoction medicament for treating pityriasis
05/30/2012CN101306108B Decoction for treating greasiness seborrheic dermatitis
05/30/2012CN101272775B Cosmetic compositions comprising hydroxyfatty acids
05/30/2012CN101259289B Methods and compositions for therapeutic use of RNA interference
05/30/2012CN101199823B Tincture medicament for treating condyloma acuminatum
05/30/2012CN101081224B Stable extended release oral dosage composition
05/30/2012CN101053403B Anti-senility anti-fatigue body-beautifying food and preparation method thereof
05/29/2012US8188276 2,4-pyrimidinediamine compounds and their uses
05/29/2012US8188275 hydrolase enzyme inhibors such as 2-(6-Chloro-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile
05/29/2012US8188259 Seven or more contiguous ribose groups linked by achiral 5' to 3' internucleoside phosphate linkages; antisense agents for gene expression inhibition of a wide variety of pathological disorders such as autoimmune diseases; suitable for oral administration
05/29/2012US8188204 Polymers, compositions and methods for use for foams, laundry detergents, shower rinses and coagulants
05/29/2012US8188100 Adenosine derivatives as A2A receptor agonists
05/29/2012US8188074 Biologically active methylene blue derivatives
05/29/2012US8188072 Benzodiazepinone compounds useful in the treatment of skin conditions
05/29/2012US8188050 Pharmaceutical and/or cosmetic composition containing peptides
05/29/2012US8188049 Peptides having activities of epidermal growth factor and its uses
05/29/2012US8187881 Methods related to wound healing
05/29/2012US8187643 Shampoo formulation for treatment of hair loss and method of use
05/29/2012US8187581 Copolymers from acryloyldimethyltaurine or an acryloyldimethyltaurate, olefinically unsaturated, noncationic, crosslinking comonomer, olefinically unsaturated, cationic comonomer having oxygen, nitrogen, sulfur or phosphorus, silicon-containing component, macromonomer having oxygen, nitrogen, sulfur
05/29/2012CA2555624C Thioamide compounds or salts thereof and cytokine production inhibitors containing the same
05/29/2012CA2496127C Piperidinyl compounds that selectively bind integrins
05/29/2012CA2495350C Use of lck inhibitor for treatment of immunologic diseases
05/29/2012CA2483214C Wound dressings comprising hydrated hydrogels and enzymes
05/29/2012CA2481036C (3z)-(3-(3-hydro-isobenzofuran-1-ylidene)-1,3-dihydro-2h-indol-2-ones as kinase inhibitors
05/29/2012CA2458611C Aminobenzophenones as interleukin 1-beta and tumour necrosis factor-alpha inhibitors
05/29/2012CA2417389C Therapeutic polyesters and polyamides
05/29/2012CA2403817C Methods of modulating hair growth
05/29/2012CA2389429C Compositions and methods for counteracting effects of reactive oxygen species and free radicals
05/24/2012WO2012068470A2 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
05/24/2012WO2012068299A2 Cbp/catenin antagonists for enhancing asymmetric division of somatic stem cells
05/24/2012WO2012068209A2 Bisthiazole inhibitors of pro-matrix metalloproteinase activation
05/24/2012WO2012067404A2 Composition for anti-aging containing artemisia annua l. as active ingredient
05/24/2012WO2012066447A1 Compositions with antibacterial and wound healing activity
05/24/2012WO2012066061A1 Pyrazolopyridines and pyrazolopyridines and their use as tyk2 inhibitors
05/24/2012WO2012065751A1 Bio-functionalized stimulus-responsive dissolvable peg-hydrogels
05/24/2012WO2012065651A1 A synergistic composition of plant extracts for treating skin diseases involving abnormal cell growth
05/24/2012WO2012020989A3 Pharmaceutical or cosmetic composition containing nicotinic acid adenine dinucleotide phosphate or derivative thereof
05/24/2012US20120130323 Delivery Product For Topical Compositions
05/24/2012US20120130069 Novel indazole derivatives or pharmaceutically acceptable salts thereof as protein kinase inhibitors for proliferative diseases treatment, and a pharmaceutical composition containing the same as an active ingredient
05/24/2012US20120130046 Tropoelastin derivatives
05/24/2012US20120129954 Carboxymethylcellulose polyethylene glycol compositions for medical uses
05/24/2012US20120129935 Nutrition with lipids and non-digestible saccharides
05/24/2012US20120129933 Ceramide dimers and use thereof as pharmaceutical preparation or cosmetic preparation
05/24/2012US20120129932 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
05/24/2012US20120129930 Ketone compounds and compositions for cholesterol management and related uses
05/24/2012US20120129929 Compound used to prevent diseases caused by aquaporin deficiency
05/24/2012US20120129906 Modulators of s1p receptors
05/24/2012US20120129897 Bis heteroaryl inhibitors of pro-matrix metalloproteinase activation
05/24/2012US20120129892 Novel pharmaceutically acceptable salts of 4-(1h-imidazol-4-ylmethyl)pyridine and their therapeutical uses
05/24/2012US20120129886 Metalloenzyme inhibitor compounds
05/24/2012US20120129872 Fused heteroaryl inhibitors of pro-matrix metalloproteinase activation
05/24/2012US20120129867 Inhibitors of protein kinases
05/24/2012US20120129843 Pyridyl-thiazolyl inhibitors of pro-matrix metalloproteinase activation
05/24/2012US20120129842 Bisthiazole inhibitors of pro-matrix metalloproteinase activation
05/24/2012US20120129838 Composition for Preventing and Treating Alopecia Disorder Containing Morgalanthamine Compounds as an Active Ingredient
05/24/2012US20120129829 Novel indole modulators of s1p receptors
05/24/2012US20120129824 Pharmaceutical Formulations Containing Corticosteroids for Topical Administration
05/24/2012US20120129819 Gel compositions for administration of pharmaceutically active compounds
05/24/2012US20120129814 Novel phosphonic acids as s1p receptor modulators
05/24/2012US20120129813 Novel compounds as receptor modulators with therapeutic utility
05/24/2012US20120129811 Tricyclic inhibitors of pro-matrix metalloproteinase activation
05/24/2012US20120129807 Methods of treatment, improvement and prevention using haloaryl substituted aminopurines
05/24/2012US20120129800 Agent For Preventing And Treating Pityriasis Versicolor
05/24/2012US20120129789 Compositions and methods for hair growth
05/24/2012US20120129785 Companion animal nutrition system
05/24/2012US20120129784 Oligopeptides And Cosmetic Compositions Containing The Oligopeptides
05/24/2012US20120129778 Ligand that bind tgf-beta receptor rii
05/24/2012US20120129776 Bioactive peptides and method of using same
05/24/2012US20120129775 Antiangiogenic small molecules and methods of use
05/24/2012US20120128805 Long-lasting gustatory and/or olfactory aversion veterinary compositions for behavior modification
05/24/2012US20120128796 Extracts and Compounds from Ficus Benghalensis for Increasing Hair Growth and Decreasing Hair Loss
05/24/2012US20120128784 Composition containing bee venom as an active ingredient for preventing and treating acne
05/24/2012US20120128777 Compositions containing lipid micro- or nanoparticles for the enhancement of the dermal action of solid particles
05/24/2012US20120128699 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
05/24/2012US20120128689 Anti-il-23 immunoglobulins
05/24/2012US20120128674 C3b antibodies and methods for the prevention and treatment of complement-associated disorders
05/24/2012US20120128642 Potency markers
05/24/2012US20120128632 Identity markers
1 ... 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 ... 1065